CDC’s Response to COVID-19 Lacks Preparedness
Despite decades of preparation for a pandemic like COVID-19, the CDC has acknowledged its inability to meet expectations in managing the crisis. Dr. Rochelle Walensky, director of the CDC, made this admission public in August 2022.
This remark came as a shock, although it was perhaps somewhat expected. The agency clearly needs significant improvement.
As noted by Walensky, the CDC struggled to deliver consistent and clear messaging to both the public and health authorities. The coordination with other public health entities was also lacking, and timely data collection and sharing with state health officials fell short.
Moreover, its guidance on school closures and recommendations for COVID-19 vaccinations, particularly for children, were seen as politicized and inconsistent with evolving data and risk assessments.
A lot of this failure can be traced back to years of congressional inaction. Lawmakers overlooked the urgency of strengthening the CDC’s capabilities to protect public health.
During the pandemic’s onset, the CDC was not positioned as the primary agency for communicating with the nation, which was a critical oversight.
The CDC will need help to address these issues. It requires collaboration with Congress to reform its structure and focus more on its core mission: preventing and controlling communicable diseases.
This is a monumental task. Health and Human Services Secretary Robert F. Kennedy Jr. has suggested initial steps, but more will be necessary.
To begin, Congress should formally establish the CDC’s role as the lead federal agency for managing infectious diseases. A recommendation from the House Subcommittee on Oversight and Investigations highlights the need for clarity in the agency’s responsibilities.
Furthermore, Congress should eliminate redundant functions and mission creep by reallocating some responsibilities of the CDC to other agencies within Health and Human Services that are more equipped to handle them.
For instance, certain health promotion tasks could be moved to the newly established Administration for a Healthy America, while the National Center for Health Statistics might better fit in the Agency for Health Quality Research. Meanwhile, the National Institutes of Health could take on the CDC’s biomedical research.
Another critical area needing attention is establishing a real-time national public health data system. Previous attempts under past leadership didn’t allocate sufficient resources to develop an effective system.
The administration and Congress also have room for improvement in how adverse vaccine events are reported. Currently, the Vaccine Adverse Event Reporting System is flawed because it depends solely on unverified self-reports, making it hard to ascertain any direct links between vaccines and injuries.
Addressing this system is vital to counteract growing vaccine hesitancy and restore public trust in vaccinations. The FDA, given its regulatory role, should oversee post-market vaccine surveillance and have the authority to respond quickly to protect public health.
While some roles should shift away from the CDC, others, like the management of the Strategic National Stockpile, should return to it. In 2018, this responsibility was transferred to a subagency within HHS, but its management proved inadequate.
The issues with the stockpile have persisted across different administrations and contributed to the supply shortages seen at the onset of the COVID-19 pandemic.
Under Kennedy’s leadership and appropriate congressional oversight, restoring the CDC’s control over the Strategic National Stockpile will enhance the country’s preparedness for future pandemics. Ensuring it has the necessary supplies will help prevent a repeat of past mistakes.
Another potential improvement involves relocating the CDC headquarters from Atlanta to Washington, D.C. In a national health emergency, the CDC director should have quick, in-person access to key government officials and lawmakers. Long-distance communication methods often don’t meet the urgent needs for policy discussions during a crisis.
The CDC is primarily staffed by career officials, but effective policy development requires a blend of sound judgment and expertise. Therefore, increasing the number of political appointees could benefit the agency’s leadership.
Moreover, decentralizing operations will enhance communication and data sharing between federal and state agencies. Throughout the pandemic, the CDC missed opportunities to engage effectively with state public health officials and gather essential ground-level information.
A lack of mechanisms to aggregate state-level data severely hampered the national response, as noted by experts.
Improving data collection and fostering direct connections between the CDC and state health agencies is crucial. Establishing CDC offices in states will streamline data analysis and support coordinated responses to national emergencies.
Lastly, creating a joint task force involving the CDC and the Department of Defense could enhance biosecurity measures. With global threats on the rise, such a partnership is crucial for rapid responses to potential outbreaks.
Relying on the World Health Organization for safety is no longer feasible, as its responses during the COVID-19 pandemic fell short. The organization disregarded important early warnings and provided misinformation about the transmissibility of the virus.
Congress must address these failures by establishing a dedicated task force of scientists and biowarfare experts to remain vigilant against emerging threats. Both agencies should also work collaboratively abroad to monitor and respond to public health challenges in real-time.
Protecting the nation from future pandemics starts with strengthening the CDC’s core mission. By adopting these critical organizational changes, Kennedy and his team can enhance the CDC’s effectiveness, allowing it to respond swiftly and clearly to safeguard public health.
